These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 34559903)

  • 1. Differential barcoding of opioid receptors trafficking.
    Degrandmaison J; Grisé O; Parent JL; Gendron L
    J Neurosci Res; 2022 Jan; 100(1):99-128. PubMed ID: 34559903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids in chronic pain.
    Przewłocki R; Przewłocka B
    Eur J Pharmacol; 2001 Oct; 429(1-3):79-91. PubMed ID: 11698029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alleviating pain with delta opioid receptor agonists: evidence from experimental models.
    Berthiaume S; Abdallah K; Blais V; Gendron L
    J Neural Transm (Vienna); 2020 Apr; 127(4):661-672. PubMed ID: 32189076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo trafficking of endogenous opioid receptors.
    Wang Y; Van Bockstaele EJ; Liu-Chen LY
    Life Sci; 2008 Nov; 83(21-22):693-9. PubMed ID: 18930741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous opiates and behavior: 2014.
    Bodnar RJ
    Peptides; 2016 Jan; 75():18-70. PubMed ID: 26551874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist.
    Linz K; Christoph T; Tzschentke TM; Koch T; Schiene K; Gautrois M; Schröder W; Kögel BY; Beier H; Englberger W; Schunk S; De Vry J; Jahnel U; Frosch S
    J Pharmacol Exp Ther; 2014 Jun; 349(3):535-48. PubMed ID: 24713140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-specific recycling profiles determine distinct potential for chronic analgesic tolerance of delta-opioid receptor (DOPr) agonists.
    Bagheri Tudashki H; Haddad Y; Charfi I; Couture R; Pineyro G
    J Cell Mol Med; 2020 May; 24(10):5718-5730. PubMed ID: 32279433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical opioid receptors: unconventional biology and therapeutic opportunities.
    Palmer CB; Meyrath M; Canals M; Kostenis E; Chevigné A; Szpakowska M
    Pharmacol Ther; 2022 May; 233():108014. PubMed ID: 34624426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nociceptin/orphanin FQ. A new opioid, a new analgesic?
    Taylor F; Dickenson A
    Neuroreport; 1998 Aug; 9(12):R65-70. PubMed ID: 9760102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous opiates and behavior: 2019.
    Bodnar RJ
    Peptides; 2021 Jul; 141():170547. PubMed ID: 33831447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The orphanin FQ/nociceptin (OFQ/N) system.
    Civelli O
    Results Probl Cell Differ; 2008; 46():1-25. PubMed ID: 18193175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain.
    Tzschentke TM; Linz K; Frosch S; Christoph T
    Pain Pract; 2017 Nov; 17(8):1032-1041. PubMed ID: 28112482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic potentials of safe opioid analgesics targeting nociceptin/orphanin FQ peptide receptor].
    Kiguchi N; Kishioka S; Ko MC
    Nihon Yakurigaku Zasshi; 2021; 156(3):139-144. PubMed ID: 33952840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The orphan opioid receptor and its endogenous ligand--nociceptin/orphanin FQ.
    Henderson G; McKnight AT
    Trends Pharmacol Sci; 1997 Aug; 18(8):293-300. PubMed ID: 9277133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripherally acting opioid analgesics and peripherally-induced analgesia.
    Martínez V; Abalo R
    Behav Pharmacol; 2020 Apr; 31(2&3):136-158. PubMed ID: 32168025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axotomy reduces the effect of analgesic opioids yet increases the effect of nociceptin on dorsal root ganglion neurons.
    Abdulla FA; Smith PA
    J Neurosci; 1998 Dec; 18(23):9685-94. PubMed ID: 9822729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.
    Podolsky AT; Sandweiss A; Hu J; Bilsky EJ; Cain JP; Kumirov VK; Lee YS; Hruby VJ; Vardanyan RS; Vanderah TW
    Life Sci; 2013 Dec; 93(25-26):1010-6. PubMed ID: 24084045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain.
    Sim LJ; Childers SR
    J Comp Neurol; 1997 Oct; 386(4):562-72. PubMed ID: 9378852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible mechanism of hypothermia induced by intracerebroventricular injection of orphanin FQ/nociceptin.
    Chen X; McClatchy DB; Geller EB; Liu-Chen L; Tallarida RJ; Adler MW
    Brain Res; 2001 Jun; 904(2):252-8. PubMed ID: 11406123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone sensitive orphanin FQ-induced analgesia in mice.
    Rossi GC; Leventhal L; Pasternak GW
    Eur J Pharmacol; 1996 Sep; 311(2-3):R7-8. PubMed ID: 8891615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.